Pharma Journalist - Page 85 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Lundbeck’s Amlenetug for MSA Receives FDA Fast Track Designation

AbbVie and Xilio Therapeutics Partner to Develop Tumor-Activated Immunotherapies

Boehringer’s Nerandomilast Hits Primary Endpoint in Phase III FIBRONEER-ILD for Pulmonary Fibrosis

Novartis Strengthens Cardiovascular Pipeline with $925 Million Anthos Therapeutics Acquisition

Bio-Thera Solutions Signs Exclusive License Deal with Intas for BAT2506 Biosimilar in the U.S.

Biodexa Secures FDA Fast Track Designation for eRapa in Familial Adenomatous Polyposis

Immuneering Signs Clinical Supply Deal with Regeneron to Test IMM-1-104 with Libtayo

Henlius and Dr. Reddy’s Partner on HLX15 Biosimilar Expansion in Europe and U.S.

Alumis and ACELYRIN to Merge, Forming Biopharma Leader in Immune-Mediated Diseases

FDA Approves EMBLAVEO for Treatment of Complicated Intra-Abdominal Infections